Stock Detail
MYREXIS INC
Biotechnology
MYRX @ Yahoo Finance | MYRX Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $2.48 | $2.56 | $-0.09 | -3.50% | 0.00 | $2.57 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $2.55 | $2.48 | 343,426 | 65.11M | 126,449.33 | -1.71 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 2.59 | 2.54 | 2.51 | 2.46 | 2.43 |
Stock Profile
Myriad Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research and development of therapeutic drug candidates. The companyÂ's activities include identification of drug targets, discovery of molecules, development of drug candidates, and design and execution of clinical programs. It develops four drug candidates that involve in human clinical trials, as well as engages in the research and development of cancer and infectious disease drugs. The company was founded in 1998 and is based in Salt Lake City, Utah. Myriad Pharmaceuticals, Inc. (NasdaqGM:MYRX) operates independently of Myriad Genetics Inc. as of June 30, 2009.